US Bancorp’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,620
| Closed | -$60.5K | – | 4248 |
|
|
2022
Q4 | $60.5K | Buy |
3,620
+235
| +7% | +$3.97K | ﹤0.01% | 2432 |
|
|
2022
Q3 | $58K | Buy |
3,385
+389
| +13% | +$6.11K | ﹤0.01% | 2450 |
|
|
2022
Q2 | $23K | Sell |
2,996
-1,496
| -33% | -$12.9K | ﹤0.01% | 2984 |
|
|
2022
Q1 | $50K | Buy |
4,492
+2,113
| +89% | +$23.7K | ﹤0.01% | 2630 |
|
|
2021
Q4 | $42K | Buy |
2,379
+2,128
| +848% | +$41.3K | ﹤0.01% | 2745 |
|
|
2021
Q3 | $5K | Buy |
251
+223
| +796% | +$5.73K | ﹤0.01% | 3678 |
|
|
2021
Q2 | $1K | Buy |
28
+2
| +8% | +$75 | ﹤0.01% | 3970 |
|
|
2021
Q1 | $1K | Buy |
+26
| New | +$1.22K | ﹤0.01% | 3854 |
|
|
2020
Q4 | – | Sell |
-26
| Closed | -$1K | – | 3927 |
|
|
2020
Q3 | $1K | Sell |
26
-5
| -16% | -$158 | ﹤0.01% | 3661 |
|
|
2020
Q2 | $1K | Buy |
+31
| New | +$873 | ﹤0.01% | 3685 |
|
US Bancorp's ONEM Position: Q1 2023 in Review
US Bancorp sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 3,620 shares — an estimated $60.5K sold.
US Bancorp first reported a position in ONEM in Q2 2020 and held it in 10 quarters. The position peaked at $60.5K in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- US Bancorp reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- US Bancorp sold 3,620 1Life Healthcare shares in Q1 2023, an estimated $60.5K.
- US Bancorp first reported a position in 1Life Healthcare in Q2 2020 and held it in 10 quarters.
- US Bancorp's 1Life Healthcare position peaked at $60.5K in Q4 2022.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.